We’ve had to make this difficult decision in order to protect vital NHS services and also to test ways of delivering this new ...
Speaking at The New York Times’s DealBook Summit, Eli Lilly’s chief executive and an obesity medicine specialist discussed ...
While President-elect Donald Trump looks poised to scrap many policies of the Biden administration, one veteran analyst says ...
Clinical trials have shown that people using weight-loss jabs, such as Wegovy and Mounjaro, lose anywhere between 16% and 21% ...
16hOpinion
Ozempic and Wegovy might be making it harder for physicians to guide patients toward lifestyle changes − the real key to long ...
Researchers have developed and are testing a small, implanted gastric balloon that people can inflate or deflate to feel full ...
Ozempic, Wegovy, and other weight-loss drugs could make millions healthier, but access and affordability barriers abound. Here's how we reported it.
State measures now seek to remove barriers to weight-loss drugs, as demand for the meds skyrockets amid rising concerns about ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback